Literature DB >> 25613289

Ultrasound-Targeted Microbubble Destruction Enhances Gene Expression of microRNA-21 in Swine Heart via Intracoronary Delivery.

Yangchun Liu1, Lang Li1, Qiang Su1, Tao Liu1, Zhiying Ma1, Huafeng Yang1.   

Abstract

BACKGROUND: Ultrasound-targeted microbubble destruction (UTMD) has proved to be a promising method for gene delivery. However, the feasibility and efficacy of UTMD-mediated gene delivery to the heart of large animals remain unclear. The present study was to explore the probability of increasing the transfection of microRNA-21 (miR-21) in swine heart by UTMD, and to search for the most suitable transfection conditions.
METHODS: We first optimized ultrasound intensity for successful miR-21 delivery. After intravenous injection of miR-21/microbubble mixture (miR-21/MB), transthoracic ultrasound irradiation (US) was applied from the left anterior chest using different intensities (1, 2, and 3 W/cm(2)). Then the efficacy of UTMD-mediated miR-21 delivery into myocardium via intracoronary injection was explored. Solution of miR-21/MB was infused intravenously or intracoronarily with US over the heart. Swine undergoing phosphate-buffered saline (PBS) injection, miR-21/MB injection via ear vein or coronary artery without US served as the control. The dynamic changes of left ventricular ejection fraction (LVEF) and serum troponin I (cTnI) after UTMD were detected, then the left ventricular myocardium was harvested for hematoxylin and eosin (H&E) staining 4 days later; the expression levels of miR-21 and programmed cell death 4 (PDCD4) were detected by quantitative real time polymerase chain reaction (qRT-PCR) and Western blot, respectively.
RESULTS: Results showed that pulse ultrasound at an intensity of 2 W/cm(2) and a 50% duty ratio for 20 minutes, there was no increase in serum cTnI, no histological sign of myocardial damage, and no noted cardiac dysfunction with relatively higher miR-21 expression (P < 0.05). Compared to miR-21/MB alone, UTMD significantly increased gene expression in myocardium regardless of the delivery routes (P < 0.05). Interestingly, the transfection efficiency was found to be a little bit higher with intracoronary injection than that with intravenous injection, though the dose for intracoronary injection was half of the intravenous injection (P < 0.05).
CONCLUSION: Under suitable conditions, UTMD can efficiently enhance gene expression in swine heart regardless of the delivery routes. The intravenous injection might be superior to intracoronary injection with less invasiveness and lower requirement of the technique. And for those undergoing percutaneous coronary intervention, intracoronary injection seems to be another alternative.
© 2015, Wiley Periodicals, Inc.

Entities:  

Keywords:  gene therapy; microRNA-21; microbubble; myocardium; ultrasound

Mesh:

Substances:

Year:  2015        PMID: 25613289     DOI: 10.1111/echo.12876

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  9 in total

1.  Ultrasound-targeted microbubble destruction-mediated microRNA-21 transfection regulated PDCD4/NF-κB/TNF-α pathway to prevent coronary microembolization-induced cardiac dysfunction.

Authors:  Q Su; L Li; Y Liu; Y Zhou; J Wang; W Wen
Journal:  Gene Ther       Date:  2015-06-16       Impact factor: 5.250

2.  Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs.

Authors:  Tommaso Di Ianni; Rajendran J C Bose; Uday K Sukumar; Sunitha Bachawal; Huaijun Wang; Arsenii Telichko; Carl Herickhoff; Elise Robinson; Sam Baker; José G Vilches-Moure; Stephen A Felt; Sanjiv S Gambhir; Ramasamy Paulmurugan; Jeremy D Dahl
Journal:  J Control Release       Date:  2019-07-18       Impact factor: 9.776

Review 3.  Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration.

Authors:  Jan Aam Kamps; Guido Krenning
Journal:  World J Cardiol       Date:  2016-02-26

Review 4.  The present and future role of ultrasound targeted microbubble destruction in preclinical studies of cardiac gene therapy.

Authors:  Lijun Qian; Barsha Thapa; Jian Hong; Yanmei Zhang; Menglin Zhu; Ming Chu; Jing Yao; Di Xu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

5.  Local Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions.

Authors:  Hong Jin; Daniel Y Li; Ekaterina Chernogubova; Changyan Sun; Albert Busch; Suzanne M Eken; Peter Saliba-Gustafsson; Hanna Winter; Greg Winski; Uwe Raaz; Isabel N Schellinger; Nancy Simon; Renate Hegenloh; Ljubica Perisic Matic; Maja Jagodic; Ewa Ehrenborg; Jaroslav Pelisek; Hans-Henning Eckstein; Ulf Hedin; Alexandra Backlund; Lars Maegdefessel
Journal:  Mol Ther       Date:  2018-01-31       Impact factor: 11.454

Review 6.  Applications of Ultrasound-Mediated Gene Delivery in Regenerative Medicine.

Authors:  Zoe Krut; Dan Gazit; Zulma Gazit; Gadi Pelled
Journal:  Bioengineering (Basel)       Date:  2022-04-27

Review 7.  Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery.

Authors:  Klazina Kooiman; Silke Roovers; Simone A G Langeveld; Robert T Kleven; Heleen Dewitte; Meaghan A O'Reilly; Jean-Michel Escoffre; Ayache Bouakaz; Martin D Verweij; Kullervo Hynynen; Ine Lentacker; Eleanor Stride; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2020-03-10       Impact factor: 2.998

8.  Ultrasound-Targeted Microbubble Destruction Enhances the Inhibitive Efficacy of miR-21 Silencing in HeLa Cells.

Authors:  Shengli Zhao; Jing Xie; Changhua Zhao; Wen Cao; Yangping Yu
Journal:  Med Sci Monit       Date:  2021-02-19

9.  Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization.

Authors:  Francesca Fasolo; Hong Jin; Greg Winski; Valentina Paloschi; Lars Maegdefessel; Ekaterina Chernogubova; Jessica Pauli; Hanna Winter; Daniel Y Li; Nadiya Glukha; Sabine Bauer; Susanne Metschl; Zhiyuan Wu; Marlys L Koschinsky; Muredach Reilly; Jaroslav Pelisek; Wolfgang Kempf; Hans-Henning Eckstein; Oliver Soehnlein; Ljubica Matic; Ulf Hedin; Alexandra Bäcklund; Claes Bergmark
Journal:  Circulation       Date:  2021-10-14       Impact factor: 29.690

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.